Synageva BioPharma GmbH in Liquidation
Company Overview
Previous Company Names
- Synageva BioPharma GmbH
Management
Synageva BioPharma Luxembourg S.à.r.l.
Luxembourg, LU
Llc member
Nicholas Moore
Freienbach
Member of the executive board + liquidator
Individual signing authority
Synageva BioPharma Corp.
Lexington, Massachusetts
Llc member
Christoph Heberlig
Sudbury
Member of the executive board
Joint signing authority (any two to sign)
Carsten Boess
Duxbury
Member of the executive board
Joint signing authority (any two to sign)
Stephen Mahoney
Sherborn
Member of the executive board
Joint signing authority (any two to sign)
Patrik Brändle
Mosnang
Member of the executive board
Joint signing authority (any two to sign)
Urs Aegerter
Rapperswil
Chairperson of the management board
Joint signing authority (any two to sign)
Christopher Heberlig
Sudbury
Member of the executive board
Joint signing authority (any two to sign)
Frank Thiel
Bettwil
Chairperson of the management board
Individual signing authority
Nicholas Moore
Schwyz
Member of the executive board
Individual signing authority
Jeffrey Fryer
Southington
Member of the executive board
Individual signing authority
Christophe Bourdon
Zürich
Chairperson of the management board
Individual signing authority
Elaine Frazer
Dublin
Member of the executive board
Individual signing authority
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 4034 | 03.05.2018 | 88 | 08.05.2018 | 4217847 |
| 2 | 3845 | 26.04.2017 | 83 | 01.05.2017 | 3495423 |
| 3 | 3520 | 12.04.2017 | 75 | 19.04.2017 | 3473999 |
| 4 | 11835 | 23.12.2015 | 252 | 29.12.2015 | 2570755 |
| 5 | 6824 | 21.07.2015 | 141 | 24.07.2015 | 2288829 |
| 6 | 12275 | 20.12.2013 | 250 | 27.12.2013 | 1260477 |
| 7 | 11061 | 19.11.2013 | 227 | 22.11.2013 | 1195423 |
Company Purpose
Entdeckung, Erforschung, Entwicklung, Fabrikation und Vertrieb von medizinisch-pharmazeutischen Produkten. Die Gesellschaft kann andere Unternehmen gründen, sich an ihnen beteiligen, sie erwerben oder finanzieren und Kooperationen eingehen sowie in- und ausländische Liegenschaften erwerben, verwalten, veräussern oder belasten.